Cycle disorders affect millions of women. Yet it takes an average of 8 to 11 years for them to receive a diagnosis, and women typically consult 5–8 healthcare providers before receiving a correct diagnosis. FEMCURE is working on a breakthrough: faster diagnostics, targeted treatments, and better prediction models, developed in collaboration between science, industry, and patients.
FEMCURE is a public-private partnership (PPP) programme funded by Health~Holland. The programme focuses on cycle disorders caused by endometriosis and uterine abnormalities such as adenomyosis, myomas, and uterine scarring after a caesarean section.
Together with hospitals, universities, research institutes, SMEs, and patient organisations, we are developing innovative products and services that fundamentally improve healthcare for women, from adolescence to menopause.
<aside>
8–11 years — average time to diagnosis for endometriosis and uterine abnormalities
5–8 healthcare providers — before a diagnosis is made
€5,2 billion — Annual costs in the Netherlands, mainly due to sick leave
~10% — of all short-term sick leave in the Netherlands is related to cycle disorders
3.5 million — women in the Netherlands affected by one or more of these conditions
</aside>
FEMCURE brings together leading partners from science, industry, and patient organisations — including Amsterdam UMC, Radboud UMC, Eindhoven University of Technology, TNO, Voices for Women, Women Inc., and a broad network of Dutch SMEs and international large companies.